We have located links that may give you full text access.
Case Reports
Journal Article
Treatment of Mycoplasma pneumoniae -Induced Rash and Mucositis With Cyclosporine [Formula: see text].
Journal of Cutaneous Medicine and Surgery 2019 November
BACKGROUND: Mycoplasma pneumoniae -induced rash and mucositis (MIRM) is a relatively newly recognized clinical entity that typically presents with predominant mucositis accompanied by variable cutaneous involvement 7-9 days after the onset of prodromal symptoms. There are no evidence-based guidelines for treatment, and current standards of care may include supportive therapy, antibiotics, corticosteroids, and intravenous immunoglobulin .
OBJECTIVE: This case series aims to describe the potential efficacy of cyclosporine A (CsA) in the treatment of MIRM.
METHODS: The present case series details our use of CsA early in the course of MIRM in 3 pediatric patients.
RESULTS: Rapid clinical resolution was observed following CsA therapy.
CONCLUSIONS: We suggest that early initiation of CsA may be an effective therapeutic option for MIRM.
OBJECTIVE: This case series aims to describe the potential efficacy of cyclosporine A (CsA) in the treatment of MIRM.
METHODS: The present case series details our use of CsA early in the course of MIRM in 3 pediatric patients.
RESULTS: Rapid clinical resolution was observed following CsA therapy.
CONCLUSIONS: We suggest that early initiation of CsA may be an effective therapeutic option for MIRM.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app